Dow Down 3.39% Nasdaq Down 4.12%

More On AVTO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Avantogen Oncology, Inc. (AVTO)

-Other OTC
0.00 0.00(0.00%) Apr 15, 2:50PM EDT
Prev Close:0.00
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:-6.86705
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.01 - 0.01
Volume:0
Avg Vol (3m):2,340
Market Cap:297.13K
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AVTO at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avantogen Oncology, Inc. acquires and develops novel compounds to treat patients with various types of cancer. The company was formerly known as Innovate Oncology, Inc. and changed its name to Avantogen Oncology, Inc. in June 2006. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback